Bruce D. Zelus

1.1k total citations
17 papers, 914 citations indexed

About

Bruce D. Zelus is a scholar working on Animal Science and Zoology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Bruce D. Zelus has authored 17 papers receiving a total of 914 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Animal Science and Zoology, 7 papers in Infectious Diseases and 6 papers in Molecular Biology. Recurrent topics in Bruce D. Zelus's work include Animal Virus Infections Studies (8 papers), SARS-CoV-2 and COVID-19 Research (6 papers) and Virus-based gene therapy research (5 papers). Bruce D. Zelus is often cited by papers focused on Animal Virus Infections Studies (8 papers), SARS-CoV-2 and COVID-19 Research (6 papers) and Virus-based gene therapy research (5 papers). Bruce D. Zelus collaborates with scholars based in United States, Canada and Italy. Bruce D. Zelus's co-authors include Kathryn V. Holmes, R. T. MacFarland, Joseph A. Beavo, Randall T. Moon, David E. Wentworth, Susan R. Weiss, Dawn H. Giebelhaus, Jeanne H. Schickli, Aurelio Bonavia and Pierre J. Talbot and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Cell Biology and Molecular and Cellular Biology.

In The Last Decade

Bruce D. Zelus

17 papers receiving 893 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bruce D. Zelus United States 13 377 366 276 139 123 17 914
Yuna Niu China 15 545 1.4× 354 1.0× 219 0.8× 94 0.7× 176 1.4× 21 1.1k
Hanxin Lin Canada 19 558 1.5× 309 0.8× 86 0.3× 63 0.5× 300 2.4× 39 1.3k
Sari Lusa Finland 12 549 1.5× 306 0.8× 39 0.1× 162 1.2× 75 0.6× 15 1.2k
Kevin D. Burroughs United States 13 191 0.5× 164 0.4× 95 0.3× 67 0.5× 283 2.3× 20 802
Franziska Kriegenburg Denmark 17 646 1.7× 257 0.7× 47 0.2× 411 3.0× 55 0.4× 26 1.1k
Annabel Borg United Kingdom 12 528 1.4× 268 0.7× 74 0.3× 71 0.5× 42 0.3× 13 874
S Rousset France 19 660 1.8× 132 0.4× 40 0.1× 290 2.1× 104 0.8× 42 1.2k
Aikaterini Alexaki United States 15 487 1.3× 310 0.8× 27 0.1× 125 0.9× 83 0.7× 23 1.0k
Shivani K Thaker United States 4 266 0.7× 174 0.5× 39 0.1× 128 0.9× 119 1.0× 5 617

Countries citing papers authored by Bruce D. Zelus

Since Specialization
Citations

This map shows the geographic impact of Bruce D. Zelus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce D. Zelus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce D. Zelus more than expected).

Fields of papers citing papers by Bruce D. Zelus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce D. Zelus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce D. Zelus. The network helps show where Bruce D. Zelus may publish in the future.

Co-authorship network of co-authors of Bruce D. Zelus

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce D. Zelus. A scholar is included among the top collaborators of Bruce D. Zelus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce D. Zelus. Bruce D. Zelus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Bonavia, Aurelio, Bruce D. Zelus, David E. Wentworth, Pierre J. Talbot, & Kathryn V. Holmes. (2003). Identification of a Receptor-Binding Domain of the Spike Glycoprotein of Human Coronavirus HCoV-229E. Journal of Virology. 77(4). 2530–2538. 162 indexed citations
2.
Zelus, Bruce D., Jeanne H. Schickli, Dianna M. Blau, Susan R. Weiss, & Kathryn V. Holmes. (2002). Conformational Changes in the Spike Glycoprotein of Murine Coronavirus Are Induced at 37°C either by Soluble Murine CEACAM1 Receptors or by pH 8. Journal of Virology. 77(2). 830–840. 97 indexed citations
3.
Tsai, Jean, Bruce D. Zelus, Kathryn V. Holmes, & Susan R. Weiss. (2002). The N-Terminal Domain of the Murine Coronavirus Spike Glycoprotein Determines the CEACAM1 Receptor Specificity of the Virus Strain. Journal of Virology. 77(2). 841–850. 52 indexed citations
4.
Holmes, Kathryn V., Bruce D. Zelus, Jeanne H. Schickli, & Susan R. Weiss. (2001). Receptor Specificity and Receptor-Induced Conformational Changes in Mouse Hepatitis Virus Spike Glycoprotein. Advances in experimental medicine and biology. 494. 173–181. 14 indexed citations
5.
Robitaille, Julie, Luisa Izzi, Eugene Daniels, et al.. (1999). Comparison of expression patterns and cell adhesion properties of the mouse biliary glycoproteins Bgp1 and Bgp2. European Journal of Biochemistry. 264(2). 534–544. 29 indexed citations
6.
Zelus, Bruce D., et al.. (1998). Neutralization of MHV-A59 by Soluble Recombinant Receptor Glycoproteins. Advances in experimental medicine and biology. 440. 3–9. 4 indexed citations
7.
Schickli, Jeanne H., David E. Wentworth, Bruce D. Zelus, Kathryn V. Holmes, & Stanley G. Sawicki. (1998). Selection in Persistently Infected Murine Cells of an MHV-A59 Variant with Extended Host Range. Advances in experimental medicine and biology. 440. 735–741. 3 indexed citations
8.
Zelus, Bruce D., David R. Wessner, Richard K. Williams, et al.. (1998). Purified, Soluble Recombinant Mouse Hepatitis Virus Receptor, Bgp1b, and Bgp2 Murine Coronavirus Receptors Differ in Mouse Hepatitis Virus Binding and Neutralizing Activities. Journal of Virology. 72(9). 7237–7244. 33 indexed citations
9.
Holmes, Kathryn V., Dina B Tresnan, & Bruce D. Zelus. (1997). Virus-Receptor Interactions in the Enteric Tract. Advances in experimental medicine and biology. 412. 125–133. 8 indexed citations
10.
Schickli, Jeanne H., Bruce D. Zelus, David E. Wentworth, Stanley G. Sawicki, & Kathryn V. Holmes. (1997). The murine coronavirus mouse hepatitis virus strain A59 from persistently infected murine cells exhibits an extended host range. Journal of Virology. 71(12). 9499–9507. 49 indexed citations
11.
Zelus, Bruce D., Richard S. Stewart, & Jeffrey Ross. (1996). The virion host shutoff protein of herpes simplex virus type 1: messenger ribonucleolytic activity in vitro. Journal of Virology. 70(4). 2411–2419. 89 indexed citations
12.
Zelus, Bruce D., et al.. (1991). Organogenesis-stage cytochrome P450 isoforms: Utilization of PCR for detection of CYP1A1 mRNA in rat conceptal tissues. Biochemical and Biophysical Research Communications. 178(1). 236–241. 12 indexed citations
13.
MacFarland, R. T., Bruce D. Zelus, & Joseph A. Beavo. (1991). High concentrations of a cGMP-stimulated phosphodiesterase mediate ANP-induced decreases in cAMP and steroidogenesis in adrenal glomerulosa cells.. Journal of Biological Chemistry. 266(1). 136–142. 175 indexed citations
14.
Kelly, Gregory M., Bruce D. Zelus, & Randall T. Moon. (1991). Identification of a calcium-dependent calmodulin-binding domain in Xenopus membrane skeleton protein 4.1. Journal of Biological Chemistry. 266(19). 12469–12473. 28 indexed citations
15.
Zelus, Bruce D., et al.. (1989). Expression of the Poly(A)-Binding Protein during Development of Xenopus laevis. Molecular and Cellular Biology. 9(6). 2756–2760. 25 indexed citations
16.
Zelus, Bruce D., Dawn H. Giebelhaus, Douglas W. Eib, Kathleen A. Kenner, & Randall T. Moon. (1989). Expression of the poly(A)-binding protein during development of Xenopus laevis.. Molecular and Cellular Biology. 9(6). 2756–2760. 85 indexed citations
17.
Giebelhaus, Dawn H., et al.. (1987). Changes in the expression of alpha-fodrin during embryonic development of Xenopus laevis.. The Journal of Cell Biology. 105(2). 843–853. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026